|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $6.6 million and $2.6 million, respectively | ||||||||||||||||||||
| Federal and state income taxes receivable | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Acquisition deposit | ||||||||||||||||||||
| Deferred issuance costs | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Derivative assets, non-current | ||||||||||||||||||||
| Investment in unconsolidated entities | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current portion of debt, net of deferred loan costs | ||||||||||||||||||||
| Deferred income | ||||||||||||||||||||
| Federal and state income taxes payable | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Long-term debt, net of deferred loan costs | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable preferred stock: | ||||||||||||||||||||
| Series A convertible preferred stock, $0.01 par value; none authorized, none issued and outstanding as of June 30, 2026 and 41 shares authorized, 41 shares issued and outstanding as of December 31, 2025 | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Total Sonida shareholders’ equity (deficit) | ||||||||||||||||||||
| Noncontrolling interest: | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities, redeemable preferred stock and equity | ||||||||||||||||||||
Loading...